Eisai Innovation
Overview
Eisai Innovation, Inc. is an investment entity formed to add cutting-edge technologies, drug modalities, and digital healthcare solutions into the Eisai network . Eisai Innovation identifies opportunities for the Eisai Group to invest in venture businesses that align with Eisai's goal of contributing to patients, focusing on cutting-edge drug discovery platforms, and new modalities, as well as leading biotechnology in focus areas of neurology, oncology, and global health .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Deciduous Therapeutics | Oct 2021 | Grant | Co-investor |
| eGenesis | Sep 2024 | Series D | - |
| RiboX Therapeutics | Jul 2022 | VC Round | Co-investor |
| Sift Biosciences | Feb 2026 | Pre Seed | Co-investor |
| Hyku Biosciences | Nov 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Eisai Innovation based?
Eisai Innovation is headquartered in Cambridge, Massachusetts, United States.
When was Eisai Innovation founded?
Eisai Innovation was founded in 2019.
How many portfolio companies does Eisai Innovation have?
Eisai Innovation has 10 portfolio companies in Caplight's dataset.
What are some companies in Eisai Innovation's portfolio?
Portfolio companies visible on Caplight include Deciduous Therapeutics, eGenesis, RiboX Therapeutics, Sift Biosciences, Hyku Biosciences.
What was Eisai Innovation's most recent investment shown here?
Eisai Innovation's most recent investment in this portfolio sample was in Sift Biosciences in 2026.
What sectors does Eisai Innovation focus on?
Eisai Innovation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Eisai Innovation focus on?
Eisai Innovation typically invests at the Early stage.
What is Eisai Innovation's AUM?
Eisai Innovation's assets under management are estimated between $0.0 and $50.0M.